Noncalcemic Vitamin D Hydroxyderivatives Inhibit Human Oral Squamous Cell Carcinoma and Down-regulate Hedgehog and WNT/β-Catenin Pathways.

Abstract:

BACKGROUND/AIM:The hormonally-active form of vitamin D, 1,25(OH)2D3, demonstrated activity against oral squamous cell carcinoma (OSCC). Cytochrome P450scc (CYP11A1)-derived vitamin D hydroxyderivatives, such as 20(OH)D3 and 1,20(OH)2D3, have overlapping beneficial effects with 1,25(OH)2D3 without causing hypercalcemia. This study sought to determine (i) whether 20(OH)D3 and 1,20(OH)2D3 exhibit antitumor effects against OSCC comparable to those of 1,25(OH)2D3 and (ii) whether these effects may stem from down-regulation of sonic hedgehog (SHH) or WNT/β-catenin signaling pathways. MATERIALS AND METHODS:Effects on CAL-27 cells were assessed by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium inner salt and spheroid assays. Signaling pathways were assessed by immunofluorescence and western blotting. RESULTS:20(OH)D3 and 1,20(OH)2D3 inhibited the growth of CAL-27 and demonstrated inhibition of WNT/β-catenin and the SHH signaling as evidenced by down-regulation of nuclear translocation of glioma-associated oncogene 1(GLI1) and β-catenin. CONCLUSION:Noncalcemic vitamin D hydroxyderivatives demonstrated antitumor activities against OSCC comparable to those of 1,25(OH)2D3 Their activities against SHH and the WNT/β-catenin pathways provide insight for a possible target for OSCC treatment.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Oak ASW,Bocheva G,Kim TK,Brożyna AA,Janjetovic Z,Athar M,Tuckey RC,Slominski AT

doi

10.21873/anticanres.14216

subject

Has Abstract

pub_date

2020-05-01 00:00:00

pages

2467-2474

issue

5

eissn

0250-7005

issn

1791-7530

pii

40/5/2467

journal_volume

40

pub_type

杂志文章
  • Gender-specific association of the VEGF -2578C > A polymorphism in Korean patients with colon cancer.

    abstract:BACKGROUND:Angiogenesis is involved in the development of cancer, promoting tumor growth, invasiveness and metastasis. Vascular endothelial growth factor (VEGF) is a potent angiogenic factor. The present case control study was carried out, to determine whether there is an association between the VEGF -2578C > A polymor...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Park HM,Hong SH,Kim JW,Oh D,Hwang SG,An HJ,Kim UK,Kim NK

    更新日期:2007-07-01 00:00:00

  • Evaluation of an Assay for MGMT Gene Promoter Methylation in Glioblastoma Samples.

    abstract:BACKGROUND/AIM:To compare the GeneXpert® O6-methylguanine DNA methyltransferase (MGMT) methylation prototype (GX MGMT) assay with pyrosequencing in glioblastomas. MATERIALS AND METHODS:The MGMT methylation status was retrospectively assessed in formalin-fixed paraffin embedded (FFPE) tumor blocks from 262 glioblastoma...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14643

    authors: Filipits M,Preusser M,Hainfellner JA,Spiegl-Kreinecker S,Berghoff AS,Lai EW,Kocmond K,Kohlway A,Weidler J,Bates M,Corless C

    更新日期:2020-11-01 00:00:00

  • Phase II study of topotecan with cisplatin in Japanese patients with small cell lung cancer.

    abstract:BACKGROUND:We conducted a phase II study of topotecan (Tp) with cisplatin (CDDP) in previously untreated Japanese patients with extensive-disease small cell lung cancer (ED-SCLC). PATIENTS AND METHODS:In stage 1, a total of 30 patients were allocated to Tp 0.65 mg/m(2) with CDDP 60 mg/m(2) day 1 or Tp 1.00 mg/m(2) wit...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Hosomi Y,Shibuya M,Niho S,Ichinose Y,Kiura K,Sakai H,Takeda K,Kudo S,Eguchi K,Matsui K,Masuda N,Ando M,Watanabe K

    更新日期:2011-10-01 00:00:00

  • High Nitric Oxide Adaptation in Isogenic Primary and Metastatic Head and Neck Cancer Cells.

    abstract:BACKGROUND/AIM:Nitric oxide (NO) functions have been studied in many cancer types, but rarely in head and neck squamous cell carcinoma (HNSCC). This study aimed to investigate the behavior of HNSCC cells following exposure to high NO (HNO). MATERIALS AND METHODS:Two pairs of isogenic HNSCC cell lines (HN18/HN17, HN30/...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14236

    authors: Utispan K,Koontongkaew S

    更新日期:2020-05-01 00:00:00

  • Hyperoxia resensitizes chemoresistant glioblastoma cells to temozolomide through unfolded protein response.

    abstract:BACKGROUND:Intratumoural hypoxia is associated with chemoresistance in glioblastoma multiforme (GBM), a highly malignant brain tumour. Adaptive response to endoplasmic reticulum stress induced by temozolomide is a major obstacle in recurrent GBM. We investigated whether hyperoxia resensitizes temozolomide-resistant GBM...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Lee D,Sun S,Ho AS,Kiang KM,Zhang XQ,Xu FF,Leung GK

    更新日期:2014-06-01 00:00:00

  • Monitoring of smokeless tobacco consumers using cytogenetic endpoints.

    abstract::Smokeless tobacco consumption is causally associated with oral cavity cancers; however, extensive cytogenetic studies have not been done. In the present study, individuals consuming dry snuff or tobacco with lime have been studied for frequency of micronucleated cells (MNC) in exfoliated buccal mucosa and chromosome a...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Trivedi AH,Dave BJ,Adhvaryu SG

    更新日期:1993-11-01 00:00:00

  • Brain Metastasis and Renal Cell Carcinoma: Prognostic Scores Assessment in the Era of Targeted Therapies.

    abstract:AIM:This study aimed at exploring several brain metastatic prognostic scores in patients with renal cell carcinoma. PATIENTS AND METHODS:We retrospectively analyzed data of 93 metastatic renal cell carcinoma patients who were diagnosed with brain metastases between October 2005 and July 2016 who received targeted ther...

    journal_title:Anticancer research

    pub_type: 杂志文章,多中心研究

    doi:10.21873/anticanres.13431

    authors: El Ali Z,Rottey S,Barthelemy P,Kotecki N,VAN Paemel R,Devrient D,Awada A,Gil T,Pannier D,Ryckewaert T,Waisse W,Clavier JB,Penel N,Vermassen T

    更新日期:2019-06-01 00:00:00

  • Immunohistochemical expression patterns of neural and neuroendocrine markers, the neural growth factor receptors and the beta-tubulin II and IV isotypes in human thymus.

    abstract::Increasing evidence suggests that neuroimmune networks play key roles in the thymic histophysiology and pathology. Prompted by this, we analyzed by immunohistochemistry the distribution of human thymic cells expressing major neural and neuroendocrine markers and neural growth factor (NGF) receptors in combination with...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Bai M,Papoudou-Bai A,Karatzias G,Doukas M,Goussia A,Stefanaki K,Rontogianni D,Dalavanga Y,Agnantis NJ,Kanavaros P

    更新日期:2008-01-01 00:00:00

  • 5-year results of cisplatin-epirubicin-vinorelbine (PEV) combination as primary chemotherapy in T2-3, N0-2 breast cancer patients: a multicentre phase II study.

    abstract:UNLABELLED:The aim this study was to assess the efficacy of cisplatin-epirubicin-vinorelbine, as primary chemotherapy, in reducing the tumour burden in T2-3 N0-2 breast carcinomas. Breast conservative surgery (BCS) rate, clinical and pathological complete response (pCR), toxicity and 5-year disease-free survival (DFS) ...

    journal_title:Anticancer research

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Barni S,Visini M,Piazza E,Ionta MT,Ardizzoia A,Arnoldi E,Fava S,Pinotti G,Torretta F,Corradini G,Villa S,Nosenzo AM,Massidda B,Cazzaniga ME

    更新日期:2007-07-01 00:00:00

  • Clinical and histopathological profile of primary or secondary osteosarcoma of the jaws.

    abstract::Osteosarcoma of the jaw is a rare disease; we report two cases, one in which the primary osteosarcoma had occurred in the sacrum and ileum, the second at the mandible. Dissemination of osteosarcoma to other organs, especially early dissemination to the lung, is common, but metastasis to the jaw has only rarely been re...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Angiero F,Moltrasio F,Cattoretti G,Valente MG

    更新日期:2011-12-01 00:00:00

  • Metastatic breast cancer patients failing first-line, anthracycline-containing chemotherapy: is further therapy of benefit?

    abstract::During the last 50 years median survival for metastatic breast cancer has not varied and remains 2-3.5 years. To assess the clinical benefit of salvage systemic therapy a retrospective analysis of metastatic breast cancer patients all homogeneously treated with a commonly used first-line anthacycline-containing cytoto...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Campora E,Gardin G,Gasco M,Rosso R,Santi L

    更新日期:1999-07-01 00:00:00

  • Antiemetic effect of ramosetron during hyperthermo-chemo-radiotherapy for esophageal cancer.

    abstract:BACKGROUND:The antiemetic effects of serotonin receptor antagonists during chemoradiotherapy for solid tumors have never been reported. We have developed hyperthermo-chemo-radiotherapy (HCR) for esophageal cancer. However, with this treatment, the more potent the chemotherapy was, the more frequently emesis was experie...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Morita M,Kuwano H,Ohno S,Kitamura K,Sugimachi K

    更新日期:2000-09-01 00:00:00

  • Induction of tumor degeneration by sodium benzylideneascorbate.

    abstract::Intravenous administration of sodium benzylideneascorbate (SBA) rapidly necrotized inoperable human lung cancer, and induced degeneration of 3'-methyl-4-dimethylaminoazobenzene-induced rat hepatocellular carcinoma (vacuolar, eosinophilic degeneration, nuclear debris) without affecting the serum glutamic oxaloacetic tr...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Sakagami H,Asano K,Fukuchi K,Gomi K,Ota H,Kazama K,Tanuma S,Kochi M

    更新日期:1991-07-01 00:00:00

  • Neoadjuvant epirubicin/docetaxel (ET) concomitant chemotherapy for primary breast cancer with tumor diameter >=3.1 cm: results of the Kyushu ET therapy phase II trial.

    abstract:AIM:Neoadjuvant epirubicin/docetaxel (ET) combination chemotherapy was administered to breast cancer patients in order to investigate their clinical and pathological response. Moreover, the breast-conserving surgery (BCS) rate, disease-free (DFS) and overall survival (OS), safety profile and the correlation of biologic...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Nishimura R,Rai Y,Matsuo F,Anan K,Hara S,Imamura S,Itoyanagi N,Kato M,Okido M,Kudaka M,Ishikawa E,Kamada Y,Watanabe R,Shirouzu M,Mitsuyama S,Takamatsu Y,Tamura K

    更新日期:2012-08-01 00:00:00

  • Quantitative structure-cytotoxicity relationship analysis of phenoxazine derivatives by semiempirical molecular-orbital method.

    abstract::A semiempirical molecular-orbital method (CAChe) was applied to delineate the relationship between the cytotoxicity (evaluated by 50% cytotoxic concentration, CC50) of fifteen phenoxazine derivatives and eleven physical parameters (descriptors). Most of the phenoxazine derivatives had extended and planar structure. Th...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ishihara M,Kawase M,Westman G,Samuelsson K,Motohashi N,Sakagami H

    更新日期:2007-11-01 00:00:00

  • Antitumor and chemopreventive effects of a clomiphene analog, MDL 103,323, in mammary carcinoma.

    abstract::MDL 103,323, an enclomiphene analog, was tested for binding to the estrogen receptor, inhibition of human tumor xenografts and prevention of carcinogen-induced mammary tumors. MDL 103,323 had 5-6 fold greater affinity for the human estrogen receptor than did either tamoxifen or enclomiphene. Consistent with enhanced b...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Bitonti AJ,Baumann RJ,Bush TL,Cashman EA,Wright CL,Prakash NJ

    更新日期:1996-09-01 00:00:00

  • Kinetics of HER2/neu ECD in 45 patients treated with trastuzumab (Herceptin) between January 2001 and June 2005 at the Grenoble University Hospital.

    abstract:UNLABELLED:The aim of this study was to evaluate the utility of HER2/neu ECD concentration as a marker of the efficacity of clinical response to Herceptin. PATIENTS AND METHODS:Iterative measurements of HER2/neu ECD (ELISA c-erbB2/c-neu Rapid Format Elisa kit QIA10 Calbiochem) concentrations in 45 patients treated wit...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Gauchez AS,Colonna M,Brand FX,Ravanel N,Pasquier D,Payan R,Mousseau M

    更新日期:2009-05-01 00:00:00

  • Patterns of Care in Pediatric Craniopharyngioma: Outcomes Following Definitive Radiotherapy.

    abstract:BACKGROUND/AIM:Few data are available on the utility of definitive radiation therapy (RT) for pediatric craniopharyngioma. This study sought to evaluate practice patterns and patient outcomes using the Surveillance Epidemiology and End Results database from 2004-2014. MATERIALS AND METHODS:Overall survival (OS) was co...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13178

    authors: Hill TK,Baine MJ,Verma V,Alam M,Lyden ER,Lin C,Connolly EP,Zhang C

    更新日期:2019-02-01 00:00:00

  • Clonazepam for chemotherapy-induced nausea and vomiting (CINV).

    abstract:BACKGROUND:A 51-year-old woman experienced refractory chemotherapy-induced nausea and vomiting (CINV) in spite of extensive antiemetic therapy, including 5-HT3 antagonists, corticosteroids, dopamine antagonists and antihistamines. CASE REPORT:We administered the patient clonazepam. After taking clonazepam, the patient...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Koga M,Nakadozono M,Nukariya K,Nogi H,Kobayashi T,Nakayama K

    更新日期:2008-07-01 00:00:00

  • Female Gender Is an Age-dependent Negative Prognostic Factor for Patients with Upper Tract Urothelial Carcinoma.

    abstract:AIM:To analyze female gender as a possible age-dependent prognostic factor for overall (OS) and cancer-specific survival (CSS) in patients with upper urinary tract urothelial carcinoma (UUTUC) after radical nephroureterectomy (RNU). PATIENTS AND METHODS:A total of 167 men and 101 women with UUTUC treated with RNU with...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Sikic D,Wach S,Taubert H,Richterstetter M,Kunath F,Goebell PJ,Schick S,Olbert P,Huber J,Wullich B,Keck B

    更新日期:2015-07-01 00:00:00

  • Preparation and biological characterization of conjugates consisting of ricin and a tumor-specific non-internalizing MAb.

    abstract::MOv18, a non-internalizing monoclonal antibody (MAb) with restricted tumor specificity, was conjugated to ricin toxin (RT). According to their ability to bind to galactose residues of Sepharose 6B, the immunoconjugates were fractionated into Bound and Unbound MOv18-RT. The two conjugates could be distinguished by SDS-...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Cogliati T,Brusa P,Canevari S,Caldera M,Mezzanzanica D,Dosio F,Cattel L,Colnaghi MI

    更新日期:1991-01-01 00:00:00

  • PTEN loss induces epithelial--mesenchymal transition in human colon cancer cells.

    abstract:BACKGROUND:The epithelial-mesenchymal transition is a critical early event in the invasion and metastasis of many types of cancer, including colorectal cancer (CRC). Chronic inflammation is an inducer of several cancer types and inflammatory cytokines have been implicated in tumor invasion. MATERIALS AND METHODS:Human...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Bowen KA,Doan HQ,Zhou BP,Wang Q,Zhou Y,Rychahou PG,Evers BM

    更新日期:2009-11-01 00:00:00

  • Effects of arsenic compounds on growth, cell-cycle distribution and apoptosis of tretinoin-resistant human promyelocytic leukemia cells.

    abstract:BACKGROUND/AIM:The effects of inorganic and organic arsenicals on proliferation, cell-cycle distribution, and apoptosis of all-transretinoic acid (ATRA)-resistant human promyelocytic leukemia HL-60 (HL-60-R2) cells were herein investigated. MATERIALS AND METHODS:Cell proliferation was examined by 3-(4,5-dimethylthiazo...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Sakai C,Arai M,Tanaka S,Onda K,Sugiyama K,Hirano T

    更新日期:2014-11-01 00:00:00

  • Multicenter evaluation of the Elecsys CA 125 II assay.

    abstract::The technical performance and clinical usefulness of the newly developed Elecsys CA 125 II assay (Boehringer Mannheim) was evaluated in a multicenter study. Imprecision studies were carried out using control sera and human pool sera with CA 125 concentrations from 11 to 1026 U/ml. Within-run CVs between 0.7 to 4.8% (m...

    journal_title:Anticancer research

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Hubl W,Chan DW,Van Ingen HE,Miyachi H,Molina R,Filella X,Pitzel L,Ruibal A,Rymer JC,Bagnard G,Domke I

    更新日期:1999-07-01 00:00:00

  • Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines.

    abstract:BACKGROUND:Melanoma cells express the nuclear vitamin D receptor (VDR), indicating that malignant melanoma represents a promising target for treatment with 1,25-dihydroxyvitamin D3 (1,25(OH)(2)D(3)) or its analogs. We previously showed that some melanoma cell lines are resistant to the antiproliferative effects of 1,25...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Essa S,Reichrath S,Mahlknecht U,Montenarh M,Vogt T,Reichrath J

    更新日期:2012-01-01 00:00:00

  • Correlation of in vitro cytotoxicity with preclinical in vivo antitumor activity.

    abstract::Several human and murine tumor cell lines were evaluated in an in vitro cytotoxicity assay as prescreens for fermentation extracts and pure materials subsequently tested in vivo against P388 leukemia or B16 melanoma. Each material, regardless of its in vitro cytotoxicity, was evaluated in vivo. At the criteria levels ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Rose WC,Schurig JE,Meeker JB

    更新日期:1988-05-01 00:00:00

  • The value of pemetrexed for the treatment of malignant pleural mesothelioma: a comprehensive review.

    abstract::This review aims to provide insight into treatment of malignant pleural mesothelioma (MPM) considering effects on survival, quality of life (QoL) and costs, in order to determine the value of pemetrexed in MPM treatment. Cisplatin in combination with pemetrexed or raltitrexed increased survival in MPM, whereas vinorel...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Boons CC,VAN Tulder MW,Burgers JA,Beckeringh JJ,Wagner C,Hugtenburg JG

    更新日期:2013-09-01 00:00:00

  • Heat-shock protein 27 is phosphorylated in gemcitabine-resistant pancreatic cancer cells.

    abstract:BACKGROUND:Gemcitabine (2'-deoxy-2'-difluorodeoxycytidine: Gemzar) (GEM) appears to be the only effective anticancer drug for pancreatic cancer, but it has little impact on outcome due to a high level of inherent and acquired tumor resistance. Our previous proteomic study demonstrated that the expression of three spots...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Taba K,Kuramitsu Y,Ryozawa S,Yoshida K,Tanaka T,Maehara S,Maehara Y,Sakaida I,Nakamura K

    更新日期:2010-07-01 00:00:00

  • Pancreas Cancer Surgery in Octogenarians - Should We or Should We Not?

    abstract:BACKGROUND/AIM:In this study we aimed to determine if advanced age represents a risk factor for negative perioperative and long-term outcome in patients undergoing curative surgery ductal pancreatic adenocarcinoma surgery. PATIENTS AND METHODS:Two-hundred-twenty-one consecutive patients, twelve (6%) patients ≥80 years...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Marsoner K,Kornprat P,Sodeck G,Schagerl J,Langeder R,Csengeri D,Wagner D,Mischinger HJ,Haybaeck J

    更新日期:2016-04-01 00:00:00

  • The Use of Toll-like Receptor 4 Agonist to Reshape the Immune Signature in Ovarian Cancer.

    abstract:BACKGROUND:Dendritic cell (DC) mono-immunotherapy has not been successful so far in ovarian cancer. The addition of a toll-like receptor (TLR) agonist has the potential to boost the innate immune system, in addition to the adoptive immune response initiated by DCs. MATERIALS AND METHODS:ID8-fLuc C57BL/6 mice were inje...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11162

    authors: Vindevogel E,Baert T,VAN Hoylandt A,Verbist G,Vande Velde G,Garg AD,Agostinis P,Vergote I,Coosemans AN

    更新日期:2016-11-01 00:00:00